Among the many genetic alterations in CRC, particular point mutations in three oncogenes, KRAS, PIK3CA and BRAF, occur at sufficiently high frequencies to be implicated in disease pathogenesis and as targets for molecular therapy (Wood et al, 2007). Here, BRAF is linked to colorectal carcinoma.